Disappearance of Streptococcus pyogenes macrolides resistance in an area of northeastern Italy: A possible link with rational long-acting macrolide consumption;Scomparsa della resistenza di Streptococcus pyogenes ai macrolidi in un'area del nord est e possibile nesso con il razionale utilizzo di molecole long-acting

Infezioni in Medicina

Volumn 17, Issue 2, 2009, Pages 82-87

  De Rosa, Rita ^a   Avolio, Manuela ^a   Stano, Paola ^a   Modolo, Maria Luisa ^a   Camporese, Alessandro ^a  

^a S MARIA DEGLI ANGELI HOSPITAL   (Italy)

Author keywords

Long acting macrolides; Macrolides resistance; Streptococcus pyogenes

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG USE; GROUP A STREPTOCOCCAL INFECTION; ITALY; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CLARITHROMYCIN; DELAYED-ACTION PREPARATIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG UTILIZATION; ERYTHROMYCIN; HUMANS; ITALY; MACROLIDES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 67650876187     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Seppala H., Klaukka T., Vuopio-Varkila J. et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N. Engl. J. Med. 337, 441-446, 1997.
2. Cizman M., Pokorn M., Seme K., Orazem A., Paragi M. The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens. J. Antimicrob. Chemother. 47, 475-477, 2001. (Pubitemid 32303418)
3. Kaplan E.L., Cornaglia G. Persistent Macrolide Resistance among Group A Streptococci: The Lack of Accomplishment after 4 Decades. Clin. Infect. Dis. 41, 609-611, 2005. (Pubitemid 41170347)
4. Bassetti M, Mantero E., Gatti G., Di Biagio A., Bassetti D. Streptococcus pyogenes erythromycin resistance in Italy. Emerg. Infect. Dis. 5, 302-303, 1999. (Pubitemid 29200637)
5. García-Rey C., Aguilar L., Baquero F., Casal J., Martín J.E. Pharmacoepidemiological Analysis of Provincial Differences between Consumption of Macrolides and Rates of Erythromycin Resistance among Streptococcus pyogenes Isolates in Spain. J. Clin. Microbiol. 40 (8), 29592963, 2002.
6. Camporese A., Tizianel G., Santalena G. Osservatorio epidemiologico sulle resistenze di Streptococcus pyogenes a macrolidi e lincosamidi. Infez. Med. 2, 74-78, 1996.
7. Gagliotti C., Nobilio L., Milandri M., Moro M.L., for the Emilia-Romagna Antibiotic Resistance Study Group. Macrolide Prescriptions and Erythromycin Resistance of Streptococcus pyiogenes. Clin. Infect. Dis. 42, 1153-1156, 2006.
8. Il Registro delle Resistenze agli Antibiotici della Regione Friuli Venezia Giulia: Dati del triennio 2004-2006. Regione Autonoma FVG, Agenzia Regionale della Sanità, 2007.
9. Granizo J.J., Aguilar L., Casal J., Dal-Re R., Baquero F. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J. Antimicrob. Chemother. 46, 959-964, 2000.
10. Hjaltested E.K., Vilhelmsson S.E., Kristinsson K.G. Rapid increase of erythromycin-resistant Streptococcus pyogenes in Iceland [abstract 1217]. In: Programs and abstracts of the 39th International Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 1999, Abstract 156, American Society for Microbiology, Washington, DC.
11. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing. Eightteenth informational supplement M100-S17. Clinical and Laboratory Standards Institute, Wayne, Pa.
12. Baquero F. Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption? J. Chemother.11, 35-43, 1999. (Pubitemid 29159251)
13. Albrich W.C., Monnet D.L., Harbarth S. Antibiotic Selection Pressure and Resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg. Infect. Dis. 10 (3), 514-517, 2004.
14. Blondeau J.M. Differential impact of macrolide compounds in the selection of macrolide non susceptible Streptococcus pneumoniae. Therapy 2(6), 813-818, 2006.
15. Drlica K. The mutant selection window and antimicrobial resistance. J. Antimicrobial. Chemother. 52, 11-17, 2003. (Pubitemid 36850078)
16. Blondeau J.M., Hansen G., Metzler K.L., Hedlin P. The role of PK/PD parameters to avoid selection and increase of resistance: mutant prevention concentration. J. Chemother. 16, 1-19, 2004. (Pubitemid 39037137)
17. Richter S.S., Heilmann K.P., Beekmann S.E., et al. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin. Infect. Dis. 41, 599-608, 2005.
18. Molinari G., Chatwal G.S. Role played by the fibronectin-binding protein SfbI (Protein F1) of Streptococcus pyogenes in bacterial internalization by epithelial cells. J. Infect. Dis. 179, 1049-1050, 1999. (Pubitemid 29159360)